189 related articles for article (PubMed ID: 12023964)
1. Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex.
Ghersi G; Dong H; Goldstein LA; Yeh Y; Hakkinen L; Larjava HS; Chen WT
J Biol Chem; 2002 Aug; 277(32):29231-41. PubMed ID: 12023964
[TBL] [Abstract][Full Text] [Related]
2. The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices.
Ghersi G; Zhao Q; Salamone M; Yeh Y; Zucker S; Chen WT
Cancer Res; 2006 May; 66(9):4652-61. PubMed ID: 16651416
[TBL] [Abstract][Full Text] [Related]
3. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease.
Piñeiro-Sánchez ML; Goldstein LA; Dodt J; Howard L; Yeh Y; Tran H; Argraves WS; Chen WT
J Biol Chem; 1997 Mar; 272(12):7595-601. PubMed ID: 9065413
[TBL] [Abstract][Full Text] [Related]
4. Seprase: an overview of an important matrix serine protease.
O'Brien P; O'Connor BF
Biochim Biophys Acta; 2008 Sep; 1784(9):1130-45. PubMed ID: 18262497
[TBL] [Abstract][Full Text] [Related]
5. Seprase-dPPIV association and prolyl peptidase and gelatinase activities of the protease complex.
Ghersi G; Dong H; Goldstein LA; Yeh Y; Hakkinen L; Larjava HS; Chen WT
Adv Exp Med Biol; 2003; 524():87-94. PubMed ID: 12675228
[No Abstract] [Full Text] [Related]
6. Proteases associated with invadopodia, and their role in degradation of extracellular matrix.
Chen WT
Enzyme Protein; 1996; 49(1-3):59-71. PubMed ID: 8796997
[TBL] [Abstract][Full Text] [Related]
7. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells.
Wesley UV; Tiwari S; Houghton AN
Int J Cancer; 2004 May; 109(6):855-66. PubMed ID: 15027119
[TBL] [Abstract][Full Text] [Related]
8. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells.
Monsky WL; Lin CY; Aoyama A; Kelly T; Akiyama SK; Mueller SC; Chen WT
Cancer Res; 1994 Nov; 54(21):5702-10. PubMed ID: 7923219
[TBL] [Abstract][Full Text] [Related]
9. DPPIV and seprase in cancer invasion and angiogenesis.
Chen WT
Adv Exp Med Biol; 2003; 524():197-203. PubMed ID: 12675240
[No Abstract] [Full Text] [Related]
10. DPPIV, seprase, and related serine peptidases in multiple cellular functions.
Chen WT; Kelly T; Ghersi G
Curr Top Dev Biol; 2003; 54():207-32. PubMed ID: 12696751
[No Abstract] [Full Text] [Related]
11. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
12. Seprase complexes in cellular invasiveness.
Chen WT; Kelly T
Cancer Metastasis Rev; 2003; 22(2-3):259-69. PubMed ID: 12785000
[TBL] [Abstract][Full Text] [Related]
13. A novel protease-docking function of integrin at invadopodia.
Mueller SC; Ghersi G; Akiyama SK; Sang QX; Howard L; Pineiro-Sanchez M; Nakahara H; Yeh Y; Chen WT
J Biol Chem; 1999 Aug; 274(35):24947-52. PubMed ID: 10455171
[TBL] [Abstract][Full Text] [Related]
14. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.
Wesley UV; Albino AP; Tiwari S; Houghton AN
J Exp Med; 1999 Aug; 190(3):311-22. PubMed ID: 10430620
[TBL] [Abstract][Full Text] [Related]
15. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
[TBL] [Abstract][Full Text] [Related]
16. Activation of EDTA-resistant gelatinases in malignant human tumors.
Chen D; Kennedy A; Wang JY; Zeng W; Zhao Q; Pearl M; Zhang M; Suo Z; Nesland JM; Qiao Y; Ng AK; Hirashima N; Yamane T; Mori Y; Mitsumata M; Ghersi G; Chen WT
Cancer Res; 2006 Oct; 66(20):9977-85. PubMed ID: 17047060
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Scanlan MJ; Raj BK; Calvo B; Garin-Chesa P; Sanz-Moncasi MP; Healey JH; Old LJ; Rettig WJ
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5657-61. PubMed ID: 7911242
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
Edosada CY; Quan C; Wiesmann C; Tran T; Sutherlin D; Reynolds M; Elliott JM; Raab H; Fairbrother W; Wolf BB
J Biol Chem; 2006 Mar; 281(11):7437-44. PubMed ID: 16410248
[TBL] [Abstract][Full Text] [Related]
19. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma.
Mori Y; Kono K; Matsumoto Y; Fujii H; Yamane T; Mitsumata M; Chen WT
Oncology; 2004; 67(5-6):411-9. PubMed ID: 15713998
[TBL] [Abstract][Full Text] [Related]
20. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha.
Aertgeerts K; Levin I; Shi L; Snell GP; Jennings A; Prasad GS; Zhang Y; Kraus ML; Salakian S; Sridhar V; Wijnands R; Tennant MG
J Biol Chem; 2005 May; 280(20):19441-4. PubMed ID: 15809306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
